Drugs / ADO09
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03916640 | Jan → Mar 2019 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03981627 | Jun 2019 → Jun 2020 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADO09 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03981627 ↗ |
| Route | Subcutaneous | “Subcutaneous injection of ADO09 formulation” NCT03916640 ↗ |